Merck Financial News

24.01 / 19:15

Merck Research show hospital recommendations prevention Vaccines Single-dose HPV jab is enough to prevent cervical cancer, Indian study finds

New Delhi: A single-dose human papillomavirus vaccination (HPV), especially given to adolescent girls in the age group of 10-14 years, can help prevent cervical cancer, says a new study published in the journal Human Vaccines and Immunotherapeutics. The study, conducted at hospitals across India, found that 10 years after vaccination, a high proportion of single- dose recipients still had antibody titers against HPV types 16 and 18 with the proportion being slightly higher among 10-14-year-olds than those aged 15-18.

04.01 / 11:59

UPS Merck trends Trade Gilead performer 2024 Eli Lilly stock rally extends as BofA names it top biopharma pick for 2024

Eli Lilly & Co. (NYSE:LLY) added 4.3% Wednesday, marking its strongest performance in two months, following Bank of America's designation of the drugmaker as its top pick among large cap biopharmaceutical companies for 2024.

31.12 / 13:01

Merck vaccine country hospital recommendations prevention medicines India’s cervical cancer drug, Cervavac, as efficient as global medicines: Lancet

NEW DELHI : India’s first indigenously developed vaccine for the prevention of cervical cancer has the same efficacy as those procured from other countries, according to a recent study published in the medical journal Lancet. Serum Institute of India developed the vaccine, called Cervavac, to be administered to youngsters between ages 9 and 26. The vaccine, rolled out earlier this year, is available in private hospitals, where the cost has been set at ₹1,400-1,600.

29.12 / 20:13

Target CEO Merck 2020 Healthtech company Qure.ai to hit fund trail

Qure.ai, a Mumbai-based healthtech firm that uses artificial intelligence (AI) for medical imaging diagnostics, is gearing up for a large fundraise early next year to fund business expansion organically as well as through acquisitions, its CEO said. «We will be raising more funds in a few months,» Prashant Warier, chief executive of Qure.ai, told ET in an interview. He declined to specify the quantum of funds Qure.ai plans to raise but said it would be in «triple digits». As for acquisitions, Qure.ai is eyeing companies that have complementary solutions as well as market access in certain geographies, Warier said.

26.12 / 15:44

Merck Immunic show testing recommendations patient medicines Rethinking Immunotherapy for Cancer: When Is the Best Time to Stop?

Immune-boosting drugs have revolutionized cancer care. Now doctors are experimenting with cutting them off. Immunotherapies unleash the immune system on tumors.

14.12 / 18:59

Manufacturing Platform Merck Parke Pfizer show country 2024 3 Stocks Ready to Skyrocket With a Potential 100%+ Earnings Surge in 2024

History shows that significant drops in Treasury bond yields are favorable for the stock market. Since 1980, there have been 33 instances where the yields on 10-Year Treasury bonds fell by 50 basis points or more in a month.

14.12 / 15:57

Merck Moderna Death vaccine stage reports patient 'Unlikely' Moderna can file for accelerated approval says analysts; Shares jump 12%

Moderna (NASDAQ:MRNA) shares rose more than 12% today after the company said its vaccine candidate, developed together with Merck (MRK) cuts the risk of skin cancer returning by nearly half.

14.12 / 14:29

Reuters Merck Adobe economy show reports open Wall St set for higher open after Fed hints at rate cuts

By Shristi Achar A and Johann M Cherian

14.12 / 14:26

Aware Merck economy Moderna concert reports Stock market today: After Dow hits unprecedented heights, Wall Street points still higher

Wall Street pointed toward gains one day after a powerful rally sent the Dow Jones Industrial Average to a record high as the Federal Reserve indicated that interest rate cuts are likely next year

07.12 / 16:33

Target Art Merck Seagen ImmunoGen show reports Although it took a while, targeted cancer drugs lived up to the hype

how to do it in a manner that could make them a staple of cancer care. That’s reflected in pharma companies’ sudden deep commitment to the space. In addition to AbbVie’s acquisition, other deals this year include Pfizer’s proposed $43 billion buyout of Seagen, Merck & Co’s $4 billion tie-up with Daiichi Sankyo, and a series of smaller investments from Bristol-Myers Squibb and Eli Lilly & Company.

06.12 / 13:51

Provident Extreme Merck economy Deloitte Experts performer After Covid, return to office, performance pressure keep Gen Z stressed

mental health concerns mounted in 2023. Nearly half a dozen counsellors and experts ET spoke with said they are getting an alarmingly high anxiety- and depression-related complaints from the Gen Z — who witnessed a multi-fold increase in stress levels amid rising fears of job loss, inroads of artificial intelligence at work, a tightening economy and layoffs in certain sectors.

06.12 / 08:55

JPMorgan Merck economy ADP track reports record high European shares gain on miners' boost, German DAX at fresh record high

European shares gained on Wednesday on rising bets of a peak in global interest rates, led by miners riding on higher metal prices, while Germany's benchmark DAX scaled a fresh all-time high. The pan-European STOXX 600 index climbed 0.1% by 0809 GMT, while the Germany's DAX also rose 0.1%. Basic resources gained 1.3% tracking a rise in prices of most base metals. Investors now await euro zone construction purchasing manager's index data for November, along with October retail sales to gauge the strength of the European economy amid recession concerns. Focus was also on U.S.

15.11 / 17:49

Merck Experts show testing patient US FDA staff flags concerns on Merck's chronic cough drug

(Reuters) -The U.S. Food and Drug Administration's reviewers on Wednesday flagged concerns that data on Merck's chronic cough drug might not be sufficient enough to prove the treatment's meaningful benefit, documents released ahead of their meeting this week showed.

06.11 / 16:37

CEO Merck Entertainment PepsiCo Healthcare HCA reports Financial Walt Disney Co. names PepsiCo's Hugh Johnston as chief financial officer

The Walt Disney Co. on Monday named 34-year PepsiCo veteran Hugh Johnston as its new chief financial officer

20.10 / 18:51

UPS Fighting Merck Immunic track patient Daiichi Sankyo, Merck ink $22-billion cancer drug deal

Merck & Co. agreed to buy the rights to sell Daiichi Sankyo Co.'s three experimental cancer drugs as it looks to sustain its dominance in cancer treatment. Daiichi rose as much as 18% on Friday, the biggest intraday jump since 2005, after Merck agreed to pay $4 billion upfront and as much as $22 billion to develop and market three cancer drug candidates.

20.10 / 17:19

UPS Target Merck UBS reports analyst Morgan Stanley raised to Peerperform, Merck a Buy at UBS: 4 big analyst picks

Investing.com — Here is your Pro Recap of the biggest analyst picks you may have missed today: a Buy assumption at Merch, and upgrades at Morgan Stanley , Cognizant Technology Solutions, and Union Pacific.

20.10 / 14:49

Merck CVS recommendations medicines CVS Health pulls some cough-and-cold treatments with ingredient deemed ineffective by doctors

CVS Health is pulling from its drugstore shelves some cough-and-cold treatments that contain an ingredient that has been deemed ineffective by doctors and researchers

20.10 / 03:19

UPS Target Manufacturing Merck stage exclusive Merck signs $5.5 billion deal with Daiichi for cancer therapy development

By David Dolan and Kanjyik Ghosh

19.10 / 06:35

UPS Reuters CEO Merck vaccine pandemic Merck KGaA raises prospect of return to sales growth next year

By Ludwig Burger

04.10 / 18:21

Merck Pfizer show hospital Department recommendations US plans shift of Merck COVID treatment to commercial market

By Michael Erman

12.09 / 19:35

UPS Provident MET Merck Bayer show advisers Popular nasal decongestant doesn't actually relieve congestion, FDA advisers say

Government advisers say the leading decongestant used by millions of Americans to treat nasal congestion doesn't actually work

what you should know about Merck

What is Merck and why is it important?

Merck is a significant category that draws public attention. On our site, we regularly publish news related to this subject.

Where can I find the latest updates on Merck?

All new posts about Merck can be found in the special selection. We publish information as it becomes available.

How can I verify the accuracy of information on Merck?

We rely on trusted sources to ensure that the information about Merck is well-supported and valuable for our readers.